Jacobs to Retrofit AstraZeneca’s Mfg. Facility for COVID-19 Vax

Jacobs was selected to retrofit AstraZeneca’s West Chester, OH manufacturing facility to deliver a potential COVID-19 vaccine and will provide engineering, procurement, construction management, and commissioning/qualification/validation (EPCMCQV).

Jacobs will upgrade an existing idle Fill Line to support formulation, vial filling, visual inspection and packaging of the COVID-19 vaccine at the earliest date possible in the fall of 2020.

“We’re eager to help AstraZeneca meet the challenge of providing a potential vaccine in record time,” said Jacobs People & Places Solutions, Global Operations, Senior Vice President, Ken Gilmartin. “The world is anxiously waiting for a cure for the novel Coronavirus and we are committed to using our vaccine manufacturing capabilities and doing all we can to make AstraZeneca’s ambition a reality.”